(Q44065892)

29 November 2017

title

Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy (English)

1 reference

29 November 2017

J W Pan

1

1 reference

29 November 2017

P K Coyle

2

1 reference

29 November 2017

K Bashir

3

1 reference

29 November 2017

J N Whitaker

4

1 reference

29 November 2017

L B Krupp

5

1 reference

29 November 2017

H P Hetherington

6

1 reference

29 November 2017

publication date

1 May 2002

1 reference

Multiple Sclerosis Journal

29 November 2017

published in

1 reference

29 November 2017

volume

8

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

200-206

1 reference

Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Primary and transitional progressive MS: a clinical and MRI cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Quantitative spectroscopic imaging of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Pathogenesis of tissue injury in MS lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithr

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

Total brain N-acetylaspartate: a new measure of disease load in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS802OA

10.1191/1352458502MS802OA

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference